Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -1.72% | -33.18% | -41.60% |
May. 15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
May. 14 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.60% | 141M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+1.06% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Akoya Biosciences Expects 20% Revenue Growth in 2024; Shares Gain Premarket